Picture of Steris logo

STE Steris News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

REG-BARCLAYS PLC Form 8.3 - STERIS CORPORATION <Origin Href="QuoteRef">BARC.L</Origin> <Origin Href="QuoteRef">STE.N</Origin>

Form 8.3 - STERIS CORPORATION

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the Code)

1. KEY INFORMATION

(a) Full name of discloser: Barclays PLC.
(b) Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose STERIS CORPORATION
relevant securities this form relates:
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e) Date position held/dealing undertaken: 08 October 2015
(f) In addition to the company in 1(c) above, is the discloser making YES:
disclosures in respect of any other party to the offer? SYNERGY HEALTH PLC

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: ORD
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 2,903 0.00% 286,611 0.48%
(2) Cash-settled derivatives:
284,112 0.47% 0 0.00%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 0 0.00% 0 0.00%
(4)
TOTAL: 287,015 0.48% 286,611 0.48%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form8 (Open Positions).

(b) Rights to subscribe for new securities (including directors and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant Purchase/sale Number of Price per unit
security securities
ORD Purchase 1 66.4900 USD
ORD Purchase 57 66.8200 USD
ORD Purchase 200 67.0200 USD
ORD Purchase 213 67.3000 USD
ORD Purchase 300 66.5613 USD
ORD Purchase 391 67.3100 USD
ORD Purchase 450 66.9855 USD
ORD Purchase 500 66.6252 USD
ORD Purchase 700 66.5728 USD
ORD Purchase 716 66.7678 USD
ORD Purchase 909 66.6377 USD
ORD Purchase 1,006 66.5345 USD
ORD Purchase 1,236 66.9800 USD
ORD Purchase 1,500 66.7681 USD
ORD Purchase 1,614 66.9900 USD
ORD Purchase 2,050 66.4992 USD
ORD Purchase 2,229 66.8509 USD
ORD Purchase 6,261 66.6838 USD
ORD Purchase 10,257 66.7373 USD
ORD Purchase 10,481 66.7372 USD
ORD Sale 29 67.2700 USD
ORD Sale 57 66.8200 USD
ORD Sale 100 66.2500 USD
ORD Sale 300 67.1450 USD
ORD Sale 400 66.5800 USD
ORD Sale 400 66.7400 USD
ORD Sale 500 66.6200 USD
ORD Sale 573 66.7380 USD
ORD Sale 600 67.0116 USD
ORD Sale 680 66.5985 USD
ORD Sale 800 66.5220 USD
ORD Sale 1,000 66.9180 USD
ORD Sale 1,016 66.7649 USD
ORD Sale 1,099 66.7421 USD
ORD Sale 1,171 66.5872 USD
ORD Sale 1,200 66.6739 USD
ORD Sale 1,420 66.7511 USD
ORD Sale 4,013 66.9723 USD
ORD Sale 4,583 66.5593 USD
ORD Sale 10,369 66.7372 USD
ORD Sale 10,369 66.7206 USD

(b) Cash-settled derivative transactions

Class of relevant security Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities Price per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state none

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state none

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 9 Oct 2015
Contact name: Jay Supaya
Telephone number: 020 7773 0635

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panels Market Surveillance Unit is available for consultation in relation to the Codes disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panels website at www.thetakeoverpanel.org.uk.

BARCLAYS PLC

Recent news on Steris

See all news